These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30907673)

  • 21. Long non-coding RNAs in colorectal cancer.
    Xie X; Tang B; Xiao YF; Xie R; Li BS; Dong H; Zhou JY; Yang SM
    Oncotarget; 2016 Feb; 7(5):5226-39. PubMed ID: 26637808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
    Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
    Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative analysis of the colorectal cancer proteome: potential clinical impact.
    Alnabulsi A; Murray GI
    Expert Rev Proteomics; 2016 Oct; 13(10):917-927. PubMed ID: 27598033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomics for early detection of colorectal cancer: recent updates.
    Alnabulsi A; Murray GI
    Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic biomarkers of colorectal cancer.
    Choong MK; Tsafnat G
    Clin Gastroenterol Hepatol; 2012 Jan; 10(1):9-15. PubMed ID: 21635968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
    Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
    Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
    Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
    Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Insights Into Colorectal Carcinoma.
    Requena DO; Garcia-Buitrago M
    Arch Med Res; 2020 Nov; 51(8):839-844. PubMed ID: 32962865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
    Coppedè F
    Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Precision medicine for metastatic colorectal cancer: an evolving era.
    Guler I; Askan G; Klostergaard J; Sahin IH
    Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
    [No Abstract]   [Full Text] [Related]  

  • 34. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer.
    Ng JM; Yu J
    Int J Mol Sci; 2015 Jan; 16(2):2472-96. PubMed ID: 25622259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications.
    Effendi-Ys R
    Acta Med Indones; 2017 Oct; 49(4):351-359. PubMed ID: 29348387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in prognostic biomarkers for esophageal cancer.
    Yang W; Han Y; Zhao X; Duan L; Zhou W; Wang X; Shi G; Che Y; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
    Expert Rev Mol Diagn; 2019 Feb; 19(2):109-119. PubMed ID: 30582379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic and prognostic epigenetic biomarkers in cancer.
    Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
    Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
    Ma H; Chen G; Guo M
    Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the colorectal cancer proteome for biomarkers: Current status and perspectives.
    Lee PY; Chin SF; Low TY; Jamal R
    J Proteomics; 2018 Sep; 187():93-105. PubMed ID: 29953962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical importance of DNA repair in sporadic colorectal cancer.
    Laporte GA; Leguisamo NM; Kalil AN; Saffi J
    Crit Rev Oncol Hematol; 2018 Jun; 126():168-185. PubMed ID: 29759559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.